Drug intelligence / Profile preview

Standard 2016-2017 Flu vaccine

Development stage
Unknown
Lead developer
Sanofi Pasteur
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

The Standard 2016-2017 Flu vaccine refers to the standard-dose seasonal influenza vaccine used as a comparator in clinical research conducted by the University Health Network (UHN) in Toronto. During the 2016-2017 influenza season, this vaccine was typically a trivalent or quadrivalent inactivated influenza vaccine (IIV) containing 15 μg of hemagglutinin per viral strain. It was evaluated in adult solid organ transplant (SOT) recipients to determine if a high-dose formulation (containing 60 μg per strain) provided superior immunogenicity. The vaccine works by inducing neutralizing antibodies against the hemagglutinin protein of specific influenza A and B strains selected by the World Health Organization for that season.

Other names
flu vaccine 2016-2017-University Health Network, Toronto-influenzaStandard influenza vaccineStandard 2016-2017 Flu vaccineStandard2016-2017 Flu vaccineStandard-2016-2017 Flu vaccine
02

Targets

HA (Hemagglutinin)

Beyond the preview

Go deeper on Standard 2016-2017 Flu vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Standard 2016-2017 Flu vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call